Login to Your Account

Omrix's Shares Climb After Evithrom Wins FDA Approval

By Donna Young

Wednesday, August 29, 2007
The FDA gave its nod of approval to Omrix Biopharmaceutical Inc.'s Evithrom, the first standalone human thrombin product approved since 1954 and the only such product with U.S. licensing. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription